Hubert Czerniak TV #6 - #Roślina (nie tylko lecznicza) #Eliksir zdrowia #Włączamy myślenie!

Czerniak presents CBD oil as a single‑agent replacement for three separate drugs, each of which carries organ‑damaging side effects: antidepressants, painkillers, and appetite stimulants. He notes that pharmaceutical drugs typically ‘help one thing but damage another’, whereas CBD oil lacks such toxicity. He also lists conditions that benefit: epilepsy, diabetes, Parkinson’s, neurodegenerative and autoimmune diseases, PTSD, and cardiovascular failure. He explains that the endocannabinoid tone (density of CB receptors and anandamide levels) determines stress resilience — low levels predispose to PTSD and depression. The oil’s anti‑cancer effects come from blocking blood‑vessel growth to tumours (anti‑angiogenesis) and accelerating apoptosis of damaged cells while sparing healthy ones. He contrasts Poland, where access is restricted and doctors are untrained, with Israel where medical cannabis is integrated into cancer care.

Czerniak walks through the early‑1900s chain of events: the invention of a hemp‑harvesting combine made hemp paper (stronger, lasting up to 1 000 years) far cheaper than wood‑pulp paper. Panic gripped cellulose mill owners. A paper‑mill owner (‘Hertz’, likely a Polish‑language allusion to Hearst) installed his own man as deputy director of the FBI. That deputy’s sole mission was to find and destroy cannabis plantations and to scare the public into believing cannabis was a dangerous drug. Meanwhile, doctors were using it extensively and no synthetic drug could match its efficacy. Czerniak’s point is that the decision to ban cannabis was a deliberate industrial‑profit calculation, not a public‑health measure, and that sick people have been paying the price ever since.

Czerniak frames the comparison around two contrasts. First, Israel (population ~8 million) holds around 30 % of Nobel prizes, whereas Poland (40 million) has far fewer. Second, in Israel it is forbidden to install mobile‑phone masts on residential buildings, and chemotherapy is not used for cancer treatment — implying Israel relies on cannabis‑based protocols instead. Meanwhile, the Israeli health ministry conducted over 60 training sessions with doctors on how to use cannabis preparations in medicine. In Poland, Minister Radziwiłł publicly asserts that there are no scientific proofs of cannabis’s medical value, blocking wider access. Czerniak calls this stance idiotic and urges listeners to ‘turn on thinking’.

Czerniak cites the 1941 Ford prototype as proof that hemp can replace steel in automotive manufacturing. The body resisted crowbar blows, merely springing back without cracking, akin to modern carbon‑fibre or polycarbonate racing panels. This property, combined with the fact that hemp grows rapidly and yields far more cellulose per hectare than forest timber, implies that resurrecting hemp composites could slash costs and environmental damage. The suppression, he argues, is driven by oil and chemical conglomerates that would lose profits from petroleum‑based plastics and steel.